Clinics, partnerships, products, supply and transactions. The practical work behind the advice.
Robin opened the clinic then known as the Jorja Emerson Centre, now Jorja Medical Cannabis, near Paddington, London in 2023, gaining direct experience of clinical operations, patient services, governance and commercial development.
Executive and commercial relationships with established cannabis companies, including his role as Patient Advocate Director at Cannaray from January 2020.
Commercial experience across product development, manufacturing relationships, supplier sourcing, distribution strategy and consumer brand development.
Direct experience of international medical cannabis supply into the UK since 2018, and of the commercial structures that keep supply reliable.
Commercial insight for investors, acquirers and boards, supported by specialist finance and legal advisers within the team.
Supplied the medicine for Jorja's early prescriptions, giving Robin direct experience of international medical cannabis supply into the UK.
Patient Advocate Director from January 2020, supporting patients and families seeking and undergoing treatment.
UK Market Consultant
Provided strategic consultancy to Tilray, supporting its understanding of and approach to the UK medical cannabis market, including market entry, regulatory considerations, commercial opportunities and industry engagement.
Business Development Director
Led business development activities, focusing on strategic partnerships, commercial growth, industry relationships and identifying opportunities within the pharmaceutical cannabinoid sector.
Director of Public Affairs
Provided senior leadership in public affairs, stakeholder engagement and strategic industry relations, supporting the company's position within the evolving medical cannabis and pharmaceutical landscape.
Chairman
Providing strategic leadership, corporate oversight and commercial direction for a medical cannabis and wellness business, including business development, investment strategy, partnerships and market expansion.
Bridging the gap between regulators, industry stakeholders and commercial operators.
Robin Emerson has played an active role in helping businesses navigate the UK's complex and evolving CBD regulatory environment. Drawing on his extensive experience in cannabinoid policy, industry engagement and commercial strategy, Robin worked directly with the Food Standards Agency (FSA), engaging in regulatory discussions and negotiations to help address challenges affecting the CBD sector. His involvement helped businesses better understand regulatory expectations, navigate compliance requirements and develop commercially viable strategies within the UK's regulatory framework. This experience demonstrates Robin's ability to bridge the gap between regulators, industry stakeholders and commercial operators, translating complex regulatory challenges into practical business solutions.
Client work is confidential. Relevant examples can be discussed privately during a consultation.
Market entry, product development, distribution, investment and board advisory.
Enquiries welcomed from anywhere in the world.
